Install with Codex or Claude Copy this prompt, paste it into Codex, Claude, or another assistant, and let it review the skill page and install it for you.
A direct command skips the review prompt. Inspect the source before running it.
Report to FDA: At 2-week, 4-week, and 8-week intervals (or as directed).
Non-responsive escalation: Repeated contact → certified mail with return receipt → personal visit → notify FDA.
7. Product Disposition
Option
When
Requirements
Destruction
Contamination, fundamental defects (default)
Witnessed, certificate (date/method/qty/lots), photo/video for high-value
Reconditioning
Correctable defect; FDA pre-approval
Detailed proposal, QC verification per unit, batch records
Relabeling
Labeling-only; FDA pre-approval
Proposal, per-unit verification, records
Return to mfg
Evaluation/rework
Full chain of custody
Storage: Segregated, restricted access, conspicuously marked, full inventory controls.
Accountability: Periodic reconciliation of distributed vs. returned vs. disposed quantities. Investigate discrepancies. Prevent unauthorized re-entry into distribution.
8. Recall Termination
FDA decides termination, not the company. Never unilaterally declare completion or make public statements suggesting recall has concluded without written FDA agreement.
- [ ] Final effectiveness check results (% accounted for)
- [ ] Quantity reconciliation with explanations for gaps
- [ ] Complete disposition records
- [ ] All recall notifications/communications
- [ ] Outcome summary with lessons learned
- [ ] Formal termination request
9. Post-Recall Review
Monitoring: Handle recalled product surfacing after termination; notify FDA if significant quantities found.
Retention: Complete recall file minimum 2 years beyond termination (longer per litigation holds).
Review checklist:
- [ ] Timeliness of initial HHE
- [ ] Adequacy of recall strategy and mid-course adjustments
- [ ] Effectiveness of notifications
- [ ] Efficiency of recovery and disposition
- [ ] Resource and personnel adequacy
- [ ] Plan gaps identified
- [ ] Root cause / systemic quality issues
Produce written report with CAPA recommendations tracked through QMS.
Pitfalls
Never self-terminate: Only FDA can authorize recall completion
Classification is FDA's call: Company proposes; FDA assigns final classification
Reconditioning/relabeling require pre-approval: Do not proceed without FDA authorization
Guidance evolves: Flag sections with [VERIFY CURRENT GUIDANCE] where FDA guidance may have changed
Cross-reference requirements: Medical devices — MDR reporting (21 CFR Part 803) [VERIFY]; Drugs/biologics — field alert reporting (21 CFR 314.81) [VERIFY]
International distribution: Coordinate with foreign regulatory authorities if distributing outside the US
Dual audience: Maintain legal precision for counsel while keeping operational sections accessible to non-legal staff